FDA greenlights tabletop heart/lung sensor

A zero-contact health monitor about the size and shape of an external laptop speaker—one sure to fire the imagination of many a sci-fi fan—has won de novo clearance from the FDA.

Tel Aviv-based Donisi says its tabletop system uses optics and algorithms to evaluate fully dressed persons up to 16 feet away for subtle changes in heart and respiratory rates.  

According to the company’s website, the optics piece involves detecting back-reflecting light patterns and nano-vibrations as recorded on a vertical surface illuminated by the device, which might be a wall or the patient’s own chest.

The AI supplies medical-grade remote measurements and personalized analytics, all of which the device sends to a smartphone app or other reception point for the patient and/or provider.

Donisi says it’s working with a cardiovascular research center in Israel on engineering the device to monitor specific heart-lung conditions like pulmonary congestion. It’s also working with the FDA on getting the system cleared for identifying atrial fibrillation and other advanced indications.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.